New mastitis symptom scales put to the test
NCT ID NCT06667609
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study evaluates two new methods—the M-Score and BISSI—for assessing symptom severity in non-lactational mastitis, a breast inflammation condition not related to breastfeeding. Researchers will enroll 320 women aged 18-65 with confirmed non-lactational mastitis to see if these tools are reliable and valid. The goal is to give doctors better ways to track symptoms and treatment success.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could provide doctors with reliable tools to better assess symptom severity and treatment effectiveness for non-lactational mastitis.
- What could go wrong
- This is an observational study focused on measurement tools, not a treatment trial. The tools may not prove accurate or useful in routine practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
320 people
The number who actually took part.
- Started
-
Aug 2024
- Expected to finish
-
May 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Female diagnosed with NL-GLM/PDM in China
- Ages
-
18 to 65 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Female, age between 18 and 65 years; 2. Clinically considered as Non-Lactational mastitis; 3. Clinically and Pathologically confirmed NL-GLM/PDM; 4. Patients planning to receive treatment or observation alone; 5. Signed the informed consent form Exclusion Criteria: 1. Patients with confirmed or suspected malignant breast tumors 2. Patients with bilateral mastitis (including those with bilateral Non-Lactational Mastitis occurring simultaneously or successively) 3. Pregnant.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Granulomatous mastitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chaozhou Maternal and Child Health Hospital
Chaozhou, Guangdong, 521000, China
-
Dongguan Maternal and Child Health Care Hospital
Dongguan, Guangdong, 523000, China
-
Jiangmen Maternity and Child Health Care Hospital
Jiangmen, Guangdong, 529051, China
-
Shenshan Medical Center, Sun Yat-sen Memorial Hospital
Shanwei, Guangdong, 516600, China
-
Sun Yat-sen memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong, 510120, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.